NCT05343780View on ClinicalTrials.gov

Clinical Trial to Investigate the Anti-oxidant Activity of Heptex in Patients With Apparent Risk Factors of NASH

PHASE2CompletedINTERVENTIONAL

Enrollment

142

Participants

Timeline

Start Date

May 8, 2019

Primary Completion Date

February 21, 2022

Study Completion Date

February 21, 2022

Conditions

Nonalcoholic Steatohepatitis

Interventions

DRUG

Heptex

Dukung Anak 200 mg + Milk thistle 100 mg

OTHER

Rice bran

Placebo

Trial Locations (2)

Unknown

National Hepatology & Tropical Medicine Research Instistute, Cairo

Tropical Medicine Department, Faculty of Medicine, Ain Shams University, Cairo

All Listed Sponsors

collaborator

Ain Shams University

OTHER

collaborator

National Hepatology & Tropical Medicine Research Institute

OTHER_GOV

lead

Natural Wellness Egypt

INDUSTRY

NCT05343780 - Clinical Trial to Investigate the Anti-oxidant Activity of Heptex in Patients With Apparent Risk Factors of NASH | Biotech Hunter | Biotech Hunter